David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Hastings Center Report 40 (5):16-18 (2010)
The phrase "personalized medicine" has a built-in positive spin. Simple genetic tests can sometimes predict whether a particular individual will have a positive response to a particular drug or, alternatively, suffer costly and debilitating side effects. But little attention has been given to some challenging issues of justice raised by personalized medicine. How should we determine who would have a just claim to access particular treatments, especially very expensive ones? How effective do those treatments need to be?If there were a thick, bright line separating minimal responders from maximal responders, then we could allocate these treatments in a fair and cost-effective way. But there is no bright line. The ..
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Susan Gilbert (2010). Personalized Cancer Care in an Age of Anxiety. Hastings Center Report 40 (5):18-21.
Sophie Pellé & Vanessa Nurock (2012). Of Nanochips and Persons: Toward an Ethics of Diagnostic Technology in Personalized Medicine. [REVIEW] NanoEthics 6 (3):155-165.
Sharona Hoffman & Andy Podgurski (2011). Improving Health Care Outcomes Through Personalized Comparisons of Treatment Effectiveness Based on Electronic Health Records. Journal of Law, Medicine and Ethics 39 (3):425-436.
Sean A. Valles (2012). Should Direct-to-Consumer Personalized Genomic Medicine Remain Unregulated?: A Rebuttal of the Defenses. Perspectives in Biology and Medicine 55 (2):250-265.
Koffi N. Maglo (2012). Group-Based and Personalized Care in an Age of Genomic and Evidence-Based Medicine: A Reappraisal. Perspectives in Biology and Medicine 55 (1):137-154.
Jordan Bartol (2013). Re-Examining the Gene in Personalized Genomics. Science and Education 22 (10):2529-2546.
Lisa S. Parker & Valerie B. Satkoske (2012). Ethical Dimensions of Disparities in Depression Research and Treatment in the Pharmacogenomic Era. Journal of Law, Medicine and Ethics 40 (4):886-903.
Shawneequa L. Callier (2012). Swabbing Students: Should Universities Be Allowed to Facilitate Educational DNA Testing? American Journal of Bioethics 12 (4):32-40.
Marianne Dion-Labrie, Marie-Chantal Fortin, Marie-Josée Hébert & Hubert Doucet (2010). The Use of Personalized Medicine for Patient Selection for Renal Transplantation: Physicians' Views on the Clinical and Ethical Implications. BMC Medical Ethics 11 (1):5-.
Shara Yurkiewicz (2010). The Prospects for Personalized Medicine. Hastings Center Report 40 (5):14-16.
Karen J. Maschke (2010). Wanted: Human Biospecimens. Hastings Center Report 40 (5):21-23.
Mats Hansson (2012). Where Should We Draw the Line Between Quality of Care and Other Ethical Concerns Related to Medical Registries and Biobanks? Theoretical Medicine and Bioethics 33 (4):313-323.
Clayton Neighbors, Eric R. Pedersen, Debra Kaysen, Magdalena Kulesza & Theresa Walter (2011). What Should We Do When Participants Report Dangerous Drinking? The Impact of Personalized Letters Versus General Pamphlets as a Function of Sex and Controlled Orientation. Ethics and Behavior 22 (1):1 - 15.
Timothy S. Jost (1998). Public Financing of Pain Management: Leaky Umbrellas and Ragged Safety Nets. Journal of Law, Medicine and Ethics 26 (4):290-307.
Jennifer Girod (2002). A Sustainable Medicine: Lessons From the Old Order Amish. [REVIEW] Journal of Medical Humanities 23 (1):31-42.
Added to index2010-09-29
Total downloads14 ( #130,846 of 1,679,397 )
Recent downloads (6 months)3 ( #78,650 of 1,679,397 )
How can I increase my downloads?